• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Younis, L., Abdo, L., Gaber Mohamed Aly, R., Elbannan, M. (2023). FOXP3 AND CD8 EXPRESSION IN DUCTAL CARCINOMA OF THE BREAST AND ITS RELATION TO THE CLINICOPATHOLOGICAL PARAMETERS. ALEXMED ePosters, 5(3), 2-3. doi: 10.21608/alexpo.2023.221921.1638
Layla Kamal Younis; Layla Ahmed Abdo; Rania Gaber Mohamed Aly; Malak Magdy Elbannan. "FOXP3 AND CD8 EXPRESSION IN DUCTAL CARCINOMA OF THE BREAST AND ITS RELATION TO THE CLINICOPATHOLOGICAL PARAMETERS". ALEXMED ePosters, 5, 3, 2023, 2-3. doi: 10.21608/alexpo.2023.221921.1638
Younis, L., Abdo, L., Gaber Mohamed Aly, R., Elbannan, M. (2023). 'FOXP3 AND CD8 EXPRESSION IN DUCTAL CARCINOMA OF THE BREAST AND ITS RELATION TO THE CLINICOPATHOLOGICAL PARAMETERS', ALEXMED ePosters, 5(3), pp. 2-3. doi: 10.21608/alexpo.2023.221921.1638
Younis, L., Abdo, L., Gaber Mohamed Aly, R., Elbannan, M. FOXP3 AND CD8 EXPRESSION IN DUCTAL CARCINOMA OF THE BREAST AND ITS RELATION TO THE CLINICOPATHOLOGICAL PARAMETERS. ALEXMED ePosters, 2023; 5(3): 2-3. doi: 10.21608/alexpo.2023.221921.1638

FOXP3 AND CD8 EXPRESSION IN DUCTAL CARCINOMA OF THE BREAST AND ITS RELATION TO THE CLINICOPATHOLOGICAL PARAMETERS

Article 1, Volume 5, Issue 3, September 2023, Page 2-3  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2023.221921.1638
View on SCiNiTO View on SCiNiTO
Authors
Layla Kamal Younis1; Layla Ahmed Abdo2; Rania Gaber Mohamed Aly2; Malak Magdy Elbannan email 2
1Department of Pathology, Faculty of Medicine, Alexandria University.
2Department of Pathology, Faculty of Medicine, Alexandria University
Abstract
Introduction:
Globally, breast cancer is the most frequently diagnosed cancer in women. Tumor microenvironment (TME), soluble, cellular and physical components plays a pivotal role in tumor progression. Tumor infiltrating lymphocytes (TILs( in ductal carcinoma in situ (DCIS), with and without invasive carcinoma is an emerging area of clinical research. Recent studies have linked high FOXP3 expression in T regulatory (Treg) tumor infiltrating lymphocytes (TILs) with higher grade and stage and poor clinical outcome. CD8+ cytotoxic T lymphocytes have antitumor effects by induction of tumor cell cytostasis, apoptosis, angiostasis and macrophage tumoricidal activity.Thus, examination of the balance between CD8+ and FOXP3+ T cells is crucial in breast cancer prognosis.
Aim of the Work:
The current work was carried out to evaluate the expression of CD8 and FOXP3 in DCIS and invasive breast cancer as well as CD8/FOXP3 ratio in relation to clinicopathological parameters.

Material
The present study comprised 70 retrospective cases of breast cancer .Paraffin blocks of these cases were obtained from the archives of the Pathology Department, Faculty of Medicine, Alexandria University, from January 2018 till December 2022.
Keywords
FOXP3; CD8; BREAST
Supplementary Files
download 1638 19.pdf
Statistics
Article View: 89
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.